Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,340 GBX | +1.23% | +2.58% | +16.40% |
01:24pm | ASTRAZENECA : JP Morgan remains its Buy rating | ZD |
11:35am | AstraZeneca: CHMP recommends approval of Tagrisso in the EU | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.25% | 240B | |
+40.73% | 739B | |
+31.44% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+9.53% | 210B | |
-5.11% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030